Cullinan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CGEM Key Statistics
Stock Snapshot
Cullinan Therapeutics(CGEM) stock is priced at $14.43, giving the company a market capitalization of 874.6M. It carries a P/E multiple of -3.88.
On 2026-04-03, Cullinan Therapeutics(CGEM) stock moved within a range of $13.38 to $14.62. With shares now at $14.43, the stock is trading +7.8% above its intraday low and -1.3% below the session's peak.
Trading volume for Cullinan Therapeutics(CGEM) stock has reached 1.15M, versus its average volume of 1.03M.
Over the past 52 weeks, Cullinan Therapeutics(CGEM) stock has traded between a high of $16.74 and a low of $5.68.
Over the past 52 weeks, Cullinan Therapeutics(CGEM) stock has traded between a high of $16.74 and a low of $5.68.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.